Digital Exclusives
Pharma executive Mahesh Karande WG01 has managed through three major existential challenges in developing countries. He shares advice for navigating the coronavirus pandemic.
A new breed of price gouging pharmaceutical companies is facing public outrage from consumers—and spurring discourse on drug pricing in the process.
An MBA student comes to grips with the start of his last spring semester at Wharton.
